SRx Health Solutions Announces Management and Board Changes
TAMPA, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the 'Company'), a leading global health and wellness company, today announced the following management team and Board of Directors changes. Lionel Conacher, current Board member, has been appointed as Chairman of the Board, Adesh Vora, current Executive Chairman, will remain on Board and be appointed Chief Executive Officer, Kent Cunningham, current Chief Executive Officer, will assume role as President, and Nina Martinez has been appointed Chief Financial Officer.
Adesh Vora, Chief Executive Officer of SRx Health Solutions, stated, 'We are grateful to our Board and senior management for their efforts in strengthening our team structure and enhancing corporate governance. These improvements align with our renewed vision for SRx Health's long-term strategic growth. Looking ahead, our core focus will be on supporting patients managing chronic and rare diseases, infusion services, clinical trials, and patient support programs to make healthcare simpler for our customers. At the same time, we will continue to build on our values—partnering with patients, pharmaceutical manufacturers, and prescriber relations.'
About SRx Health Solutions, Inc. SRx Health Solutions Inc. is an integrated Canadian healthcare services provider that operates within the specialty healthcare industry. The SRx network extends across all ten Canadian provinces, making it one of the most accessible providers of comprehensive, integrated, and customized specialty healthcare services in the country. SRx combines years of industry knowledge, technology, and patient-centric focus to create strategies and solutions that consistently exceed client expectations and drive critical patient care initiatives aimed to improve the wellness of Canadians. For more information on SRx Health Solutions Inc., please visit www.srxhealth.com.
Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words 'believe,' 'may,' 'estimate,' 'continue,' 'anticipate,' 'intend,' 'should,' 'plan,' 'could,' 'target,' 'potential,' 'is likely,' 'will,' 'expect' and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company's risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.
Company Contact:SRx Health Solutions, Inc.Adesh A. Vora, Chief Executive Officer
Investor Contact:KCSA Strategic CommunicationsValter Pinto, Managing DirectorT: 212-896-1254Valter@KCSA.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Sabra Health Care REIT, Inc. Thanks Clifton J. Porter II for His Board Service
TUSTIN, Calif.--(BUSINESS WIRE)-- Rick Matros, the Chair and Chief Executive Officer of Sabra Health Care REIT, Inc. ('Sabra' or the 'Company') (Nasdaq: SBRA), issued the following statement today thanking Clifton J. Porter II for his five years of Board service to the Company: 'On behalf of our Board of Directors, I want to thank Clif for his exemplary service to our Company. I know our Board and leadership team benefited greatly from his insights and expertise—I certainly did. We look forward to continuing to work with Clif in his capacity as the President and CEO of the American Health Care Association/National Center for Assisted Living (AHCA/NCAL), where we know he will continue to provide great leadership for the healthcare industry.' Sabra Health Care REIT, Inc. Thanks Clifton J. Porter II for his Board Service. Share Mr. Porter stated, 'These past five years on the Sabra Board have been one of the highlights of my career. It has been a rewarding experience to work with such an accomplished group of leaders. An operational culture drives Sabra and I am confident that the organization will continue to flourish. I look forward to continuing to support Sabra's mission in my new role.' About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a 'REIT') that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.
Vogue
an hour ago
- Vogue
Everything You Need to Know About the New Breast Cancer Vaccine
In the search for a cure for breast cancer, a major breakthrough has finally come. Biotechnology company Anixa Biosciences, Inc. announced earlier this month that its breast cancer vaccine, which is being designed with the help of the Cleveland Clinic, has completed phase 1 of its clinical testing. It will be moving forward to the next stages of development, and if all goes to plan, doctors may soon be able to stop cancerous tumors from forming. 'The vaccine is designed to mobilize the patient's immune system to find, recognize, and destroy breast cancer cells for primary prevention,' Amit Kumar, Ph.D, CEO of Anixa Biosciences, Inc., tells Vogue. 'If a patient is vaccinated and [their] immune system is trained to destroy the cancer cells when the cancer appears, the vaccinated immune system will destroy the cells before they can grow into a cell tumor.' The vaccine, which comes in a set of three shots given to patients two weeks apart, specifically targets alpha-lactalbumin, a milk protein that is produced during lactation. It is typically not found after lactation in normal breast tissue, but scientists have found that the protein is expressed in about 70% of triple-negative breast cancer (TNBC) cases. The hope, Rima Patel, MD, oncologist and assistant professor in the division of hematology and medical oncology at Mount Sinai, explains, is that the vaccine can train people's immune system to recognize the protein as harmful and attack it before it turns into cancer. 'It is designed to alert the immune system to attack a breast tumor, before it can develop or recur, and prevent it from growing,' says Dr. Patel. 'It has been studied in an early phase 1 clinical trial in 35 women who had a history of early-stage TNBC and are at high risk of recurrence, and in patients without a history of cancer but are at high risk of developing breast cancer due to a genetic predisposition or other factors. The study thus far showed that the vaccine is overall well tolerated and resulted in an immune response in most patients.' Research in mice shows that the vaccine has been successful in activating the immune system against alpha-lactalbumin and preventing breast tumors in these small creatures. While the vaccine shows promise in humans, Dr. Kumar says they have to test larger numbers and with control groups in the next phases to show its efficacy and safety.
Los Angeles Times
an hour ago
- Los Angeles Times
Canadian Asian grocery chain T&T Supermarket continues expansion in SoCal
Canada's largest Asian grocery chain is opening its second store in Southern California and the fourth in the state in Chino Hills. The T&T Supermarket will open in the Los Angeles suburb in the fall of 2026 and offer an assortment of Asian snacks, fresh produce and live seafood, according to a statement. The grocer is popular in Canada for Asian street food and a variety of hot food cooked on site. T&T Supermarket operates more than 38 stores in Vancouver, Toronto and other Canadian cities. The first U.S. location opened in Bellevue, Wash., in December 2024, and the company also has plans to open stores in Irvine, San Francisco and San Jose by the end of next year. Plans for the new store come as other grocers eye expansion in Southern California this year, including Aldi, Trader Joe's and Erewhon. The 61,000-square-foot Chino Hills store will be situated in the Crossroads Marketplace mall among Costco and PetSmart, and will be the chain's largest location in California. 'Chino Hills is a wonderful community to live, and we can't wait to add to the local food scene,' said T&T Chief Executive Tina Lee in a statement. 'We're transforming two vacant retail spaces, a former Best Buy and Bed Bath & Beyond, into one big food destination.' The store will create 350 jobs for the local community and offer unique products including Taiwanese-style rice rolls and Chinese crepes, the company said. T&T Supermarket first opened in British Columbia in 1993 and is currently run by the founder's daughter, Lee, who took over in 2014. Canadian retailer Loblaw Companies acquired the chain in 2009, though it is operated as an independent subsidiary.
